02728nas a2200361   4500000000100000008004100001260003500042653002100077100001300098700001200111700001800123700001400141700001900155700001400174700001700188700001100205700001600216700001500232700001400247700001400261700001600275700001500291700001600306700001600322700001500338700001400353245011100367856007200478300001400550490000700564520178100571022001402352       2022                            d  bScientific Foundation SPIROSKI10aGeneral Medicine1 aLubis RD1 aDarmi M1 aPrakoeswa CRS1 aAgusni RI1 aKusumaputra BH1 aAlinda MD1 aListiawan MY1 aAnum Q1 aArgentina F1 aMenaldi SL1 aGunawan H1 aYuniati R1 aMulianto NR1 aSiswati AS1 aWidasmara D1 aRusyati LMM1 aMamuaja EH1 aMuchtar V00aLeprosy Epidemiology According to Leprosy Type in 13 Teaching Hospitals in Indonesia between 2018 and 2020  uhttps://oamjms.eu/index.php/mjms/article/download/10816/8271/107109  a1812-18170 v103 a<p>BACKGROUND: Leprosy or Hansen’s disease is an infectious disease caused by Mycobacterium leprae (M. leprae) bacilli which results in chronic infections in humans that affect the peripheral nerves, skin, and other organs such as the eyes, mucous membranes, bones, and testicles. Leprosy has a variety of clinical presentations, depending on the cell-mediated immunity of the host. Leprosy is classified by the World Health Organization (WHO) as paucibacillary type (PB) and multibacillary type (MB) depending on the number of lesions. This multicenter study aims to provide representation of leprosy types and its epidemiology in Indonesia. AIM: The purpose of this study is to find out the epidemiology according to the leprosy type in 13 teaching hospitals in Indonesia between 2018 and 2020. METHODS: This is a descriptive study with cross-sectional design. All patients with the diagnosis of PB or MB type of leprosy who underwent Multidrug Therapy (MDT) treatment between 2018 and 2020 were included in this study. Data collection was carried out by tracing medical records data in 13 teaching hospitals in Indonesia. RESULTS: A total of 2129 leprosy patients were included in this study. There were 232 cases (10.8%) of PB leprosy and 1897 cases (89.1%) of MB leprosy. The average age of the patients is 38.7 years (SD ± 16.2 years). Males are more affected by leprosy (n = 1,441; 67.7%) compared to female (n = 688; 32.3%). CONCLUSION: Leprosy remains as a national health problem. The increasing cases of MB leprosy in Indonesia are caused by several factors including the lack of knowledge about leprosy, the delay in diagnosis of leprosy, and the stigma of leprosy within the community; therefore, it becomes a challenge to eliminate leprosy in Indonesia.</p>
  a1857-9655